Curevo Competitors and Similar CompaniesClear all
Curevo's competitors and similar companies include Uvax Bio, Biogen, EMS Pharma and Livzon Pharmaceutical Group.
 Uvax Bio Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2017 | Founding Date 2018 | Founding Date 1978 | Founding Date 1964 | Founding Date 1985 |
Type | Type Private | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Seattle, US HQ | Locations Wilmington, US HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations BR HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 41 | Employees 1110% increase | Employees 7,605 | Employees 12,7441% increase | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 26.7 b | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $7.5b (FY, 2025) | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $1.3b (FY, 2025) | Net income N/A | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Uvax Bio
HQ
Wilmington, US
Employees
11↑ 10% increase
Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company